News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare and Johnson & Johnson (JNJ)'s Janssen Pharmaceutica N.V. Deal Pairs Two Alzheimer's Powerhouses


12/3/2010 7:47:01 AM

Medical News Today -- GE Healthcare announced a research agreement to collaborate with Janssen Pharmaceutica NV, L.L.C. (Janssen) to identify a biosignature related to Alzheimer's disease. This research effort will combine expertise in data integration, informatics, genomics and imaging. Its goal will be to find a biosignature that may enable the detection of Alzheimer's disease before the onset of clinical symptoms. The collaboration is part of a broad portfolio of diagnostic solutions that GE Healthcare is developing in the Alzheimer's field.

Read at Reuters
Read at News Release
Read at Medical News Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES